2197480-A2 cites 5 patents.

The present invention is directed to the use of the peptide compound Pyr-His-Trp-Ser-Tyr-D-His(Bzl)-D-Leu-Arg-Pro-NHEt as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquid buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Pyr-His-Trp-Ser-Tyr-D-His(Bzl)-D-Leu-Arg-Pro-NHEt optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.

Title
Use of bfgf 1-24 and optionally (arg 8) vasopressin to treat eg s. pneumoniae infection
Application Number
EP20080785859 20080909
Publication Number
EP2197480 (A2)
Application Date
September 9, 2008
Publication Date
June 23, 2010
Inventor
Bacher Gerald
DE
Cavalli Vera
DE
Cavalli Fabio
DE
Bevec Dorian
DE
Assignee
Mondobiotech Lab
LI
IPC
A61P 09/00
A61P 37/00
A61P 35/00
A61P 31/00
A61P 03/00
A61P 25/00
A61P 11/00
A61K 38/55
A61K 38/18
A61K 38/10
A61P 09/00
A61P 37/00
A61P 35/00
A61P 31/06
A61P 31/00
A61P 03/00
A61P 25/28
A61P 11/00
A61K 38/55
A61K 38/18
A61K 38/11
View Original Source Download PDF